MedPath

asya in Dry eye

Phase 2
Conditions
Health Condition 1: H00-H59- Diseases of the eye and adnexaHealth Condition 2: H049- Disorder of lacrimal system, unspecified
Registration Number
CTRI/2023/03/050918
Lead Sponsor
CCRAS New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

1.Patient between 18-70 years of age suffering from Shushkakshipaka (DES) irrespective of sex or religion.

2.Patient having Shushkakshipaka (DES) symptoms â?? feeling of dryness, irritation, foreign body sensation, non specific ocular discomfort and chronically sore eyes, not responding to a variety of drops instilled earlier.

3.Defective blinking such as low blink rate as seen in prolonged computer and mobile phones users.

4.Vitamin A deficiency and other factors affecting ocular surface for example tropical drugs, preservative of contact lens bearers. Ocular surface allergic disease and scarring disorders.

5.Patient ready to give written consent and study till completion only will be selected.

Exclusion Criteria

1.Patient not willing for trial.

2.Allergic by patient report.

3.Pregnancy or lactating mother.

4.Current diagnosis of any of the following ocular conditions-

Acute allergic conjunctivitis, infection (bacterial, viral, protozoan or fungal infection of cornea, conjunctiva, lacrimal gland, lacrimal sac or eye lids)

5.Inflammation (retinitis, macular inflammation, choroiditis, uveitis, scleritis, episcleritis and keratitis).

6.History of patient report of ocular herpetic keratitis.

7.Ocular surgery (including cataract surgery) by patient report within six months.

8.Previous LASIK surgery or any other corneal surgery.

9.Use of glaucoma medication or history of filtering surgery for glaucoma.

10.Eye lid abnormalities that affect lid function (blepharospasm, ectropion, entropion, severe trichiasis).

11.Extensive ocular surface scarring or condition that may compromise ocular surface integrity such as Stevens Johnson syndrome, prior chemical burn, recurrent corneal erosions, persistent corneal epithelial defects prior ocular trauma etc.

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
1st, 8th, 15th, 22nd, 29th day <br/ ><br>Timepoint: 4 Weeks
Secondary Outcome Measures
NameTimeMethod
1.Visual symptoms- <br/ ><br>2.Conjunctiva- erythematic (bulbar)- <br/ ><br>3.Conjunctiva-oedema (bulbar)- <br/ ><br>4.Conjunctiva- staining- <br/ ><br>5.Cornea- staining- <br/ ><br>6.Corneal tear signs- <br/ ><br>7.Lid- meibomian glands- <br/ ><br>8.Tear film break up time (TBUT)- <br/ ><br>9.Schirmerâ??s score- <br/ ><br> <br/ ><br>Timepoint: 4 weeks
© Copyright 2025. All Rights Reserved by MedPath